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ABSTRACT Upon microbial infection, host immune cells recognize bacterial cell enve-
lope components through cognate receptors. Although bacterial cell envelope compo-
nents function as innate immune molecules, the role of the physical state of the bacte-
rial cell envelope (i.e., particulate versus soluble) in host immune activation has not been
clearly defined. Here, using two different forms of the staphylococcal cell envelope of
Staphylococcus aureus RN4220 and USA300 LAC strains, we provide biochemical and im-
munological evidence that the particulate state is required for the effective activation of
host innate immune responses. In a murine model of peritoneal infection, the particulate
form of the staphylococcal cell envelope (PCE) induced the production of chemokine (C-
X-C motif) ligand 1 (CXCL1) and CC chemokine ligand 2 (CCL2), the chemotactic cyto-
kines for neutrophils and monocytes, respectively, resulting in a strong influx of the
phagocytes into the peritoneal cavity. In contrast, compared with PCE, the soluble form
of cell envelope (SCE), which was derived from PCE by treatment with cell wall-
hydrolyzing enzymes, showed minimal activity. PCE also induced the secretion of calpro-
tectin (myeloid-related protein 8/14 [MRP8/14] complex), a phagocyte-derived antimicro-
bial protein, into the peritoneal cavity at a much higher level than did SCE. The injected
PCE particles were phagocytosed by the infiltrated neutrophils and monocytes and then
delivered to mediastinal draining lymph nodes. More importantly, intraperitoneally (i.p.)
injected PCE efficiently protected mice from S. aureus infection, which was abolished by
the depletion of either monocytes/macrophages or neutrophils. This study demonstrated
that the physical state of bacterial cells is a critical factor for efficient host immune acti-
vation and the protection of hosts from staphylococcal infections.
KEYWORDS Staphylococcus aureus, cell envelope, chemokines, host defense, innate
immunity, phagocytes
Staphylococcus aureus is a Gram-positive human pathogen causing a wide range ofdiseases in humans, ranging from skin and soft tissue infections to many life-
threatening diseases, such as pneumonia, endocarditis, and sepsis (1). In particular,
invasive infections caused by methicillin-resistant S. aureus (MRSA) are often intractable
to antibiotic therapy, leading to recurrent diseases or deaths. To solve these serious
problems, we need to develop new vaccines and find novel preventive strategies (2, 3).
The bacterial cell envelope contains many molecules recognized by host immune cells.
Therefore, the identification of bacterium-derived cell envelope components able to
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induce effective innate responses is a promising tool to develop preventive strategies
against S. aureus infection.
Host immune systems are classified into innate and acquired immunities. Innate
immunity is carried out by professional phagocytic cells, such as neutrophils, macro-
phages, and dendritic cells. The phagocytic cells recognize the components of the
bacterial cell envelope through their receptor molecules (4). The recognition of cell
envelope components by neutrophils, macrophages, and dendritic cells is essential for
the first line of the host defense to eliminate invading pathogenic microbes. Several
different families of receptors recognizing S. aureus cell envelope components have
been reported. For example, the staphylococcal lipoproteins (5), wall-teichoic acid
(WTA) (6, 7), lipoteichoic acid (LTA) (8), and peptidoglycan (PGN) (9) are recognized by
Toll-like receptor 2 (TLR-2), mannose-binding lectin (MBL), immunoglobulin superfamily
(CRIg), and NOD-like receptors (NLRs), respectively.
Purified staphylococcal cell envelopes are water-insoluble particles due to highly
cross-linked PGN structures (10, 11). This insoluble cell envelope contains not only the
cell wall surface proteins (12) but also other host cell-modulating molecules (9, 13),
such as WTA and PGN. LTA and lipoproteins are also retained in the preparation of the
cell envelope. Upon treatment with PGN-hydrolyzing enzymes (e.g., lysozyme, muta-
nolysin, and lysostaphin), this insoluble cell envelope converts to the water-soluble
state (9, 10). Although the interactions between bacterial components and their
receptors have been intensively studied for their roles in host immune activation, it is
not clearly defined how the physical state of the bacterial components plays a role in
host immune activation and protection.
Microsized particles and nanoparticles have been reported to exhibit adjuvant
activity (14). One of the main functions of particulate adjuvants, such as alum, is to
activate host innate immunity or to induce inflammatory responses around injection
sites (15). These insoluble particulate molecules are easily engulfed by host phagocytes
and are then able to activate innate immune cells, leading to the production of
host-derived cytokines, chemokines, and other factors (16). Therefore, the determina-
tion of the recognition mechanism of the S. aureus-derived particulate or soluble cell
envelope by host immune cells will be important for the understanding of host innate
immune responses against S. aureus infection and vaccine development.
In this study, to investigate the role of the physical state of the staphylococcal cell
envelope in host defense responses, we generated the particulate cell envelope (PCE)
from S. aureus RN4220 and USA300 LAC strains by mechanical breakage and extensive
washing. We also converted PCE into soluble cell envelope (SCE) by treating PCE with
peptidoglycan-hydrolyzing enzymes, such as lysostaphin and lysozyme. Using the two
different forms of staphylococcal cell envelope containing the same antigenic deter-
minants and pathogen-associated molecular pattern (PAMP) molecules, in this study,
we compared their innate immune activation and protective effect in a murine model
of peritoneal infection.
RESULTS
Characterization of staphylococcal PCE and SCE. We prepared staphylococcal
PCE from the S. aureus RN4220 wild-type strain (referred to as RN4220-PCE) based on
our published method (17, 18) (Fig. 1A). Particle size analysis showed that the RN4220-
PCE had a mean particle size of 1.085 m (Fig. 1B). The RN4220-SCE was prepared by
digesting the wild-type PCE (WT-PCE) with recombinant lysostaphin and lysozyme, as
described previously (17) (Fig. 1C). SDS-PAGE analysis of the RN4220-SCE showed
multiple protein bands (Fig. 1D), of which the 48-kDa and 35-kDa bands were identified
as the cell wall proteins SpA (S. aureus protein A) and IsdA (iron-regulated surface
determinant A), respectively (see Fig. S1 in the supplemental material). Trifluoroacetic
acid (TFA) treatment of RN4220-PCE released various sizes of WTA ribitol phosphate
moieties (17, 19), confirming the presence of WTA in the RN4220-PCE (Fig. 1E). In a dot
blot analysis, the RN4220-SCE showed a strong LTA signal, which was greatly reduced
in the SCE prepared from the mutant of ltaS, the gene encoding the LTA synthase
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(ΔltaS-SCE in Fig. 1F). Moreover, in a Western blot analysis, the lipoprotein SitC was
detected in RN4220-SCE but not in SCE prepared from the mutant of lgt, the gene
encoding lipoprotein diacylglycerol transferase (Fig. 1G). During the lipoprotein bio-
synthesis process, Lgt catalyzes the transfer of diacylglycerol to the sulfhydryl group of
a cysteine residue in the signal peptide of lipoprotein precursors and is essential to
anchor lipoproteins to the cell membrane (20). Finally, when the contents of D-Ala and
N-acetylglucosamine (GlcNAc) in RN4220-PCE and RN4220-SCE were compared, no
significant difference was observed (Fig. S2), indicating similar chemical compositions
of the two samples. Taken together, these results demonstrate that the prepared
WT-PCE and WT-SCE harbored all major staphylococcal cell envelope components (i.e.,
WTA, LTA, PGN, surface proteins, and lipoproteins) that can activate host innate
immune responses.
PCE efficiently recruits major host phagocytes. To compare the innate immune
activation capabilities of RN4220-PCE and RN4220-SCE, we injected RN4220-PCE or -SCE
into mice via the intraperitoneal (i.p.) route and examined the recruitment of neutro-
phils and monocytes to the peritoneum. At 12 h after injection of five different doses
of RN4220-PCE and -SCE, maximal numbers of neutrophils (35% of the total cell
population) were recruited at amounts of 40 g of RN4220-PCE injection (Fig. 2A).
However, at the injection dose of 40 g of RN4220-SCE, approximately five times fewer
neutrophils (7% of the total cell population) were recruited. By injection of 160 g of
FIG 1 Biochemical characterization of WT-PCE and WT-SCE. (A and C) Photo images of WT-PCE (A) and WT-SCE (C).
Lyophilized WT-PCE or WT-SCE (10 mg) was suspended 1 ml of PBS. (B) The particle size of WT-PCE was determined
three times with a laser diffraction particle size analyzer (LS12 320 model; Beckman Coulter Co.). (D) The proteins
(20 g) of WT-SCE were analyzed by SDS-PAGE gels (15%) under reducing conditions. (E) The WTA ribitol
phosphate molecules (10 g) extracted from WT-PCE were separated by PAGE gels (27%) and visualized by alcian
blue silver staining. (F) LTA analysis by dot blot immunoassay. SCEs (40 g) prepared from the RN4220 wild type
and ΔltaS isogenic mutant were spotted on the PVDF membrane with LTA standard (5 g; Sigma-Aldrich). Then,
LTA was visualized by dot blot immunoassay with anti-LTA MAb (Invitrogen). (G) Lipoprotein analysis by Western
blotting. After SDS-PAGE (upper row), the gel was immunoblotted (lower row), and then the presence of SitC
lipoprotein was detected by anti-SitC polyclonal antibody, as described previously (43). The red arrow indicates the
position of the SitC lipoprotein.
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RN4220-SCE, almost the same numbers of neutrophils corresponding to 40 g of
RN4220-PCE were recruited, indicating that SCE is four to five times weaker than is PCE
in recruiting neutrophils.
RN4220 is a laboratory strain containing multiple mutations (21). To examine
whether the immune activation property of PCE is conserved in other clinical isolates
of S. aureus, we repeated the experiment with PCE prepared from the USA300 LAC
strain, a well-characterized clinical isolate (22). As shown in Fig. 2A, USA300-PCE
recruited neutrophils as efficiently as RN4220-PCE, suggesting conservation of the
neutrophil recruitment ability of PCE among different S. aureus strains. Here, for
simplicity, we call RN4220-PCE and RN4220-SCE PCE and SCE, respectively.
Next, to test whether or not PCE treatment leads to the recruitment of different
types of host immune cells, we analyzed the recruitment of four different host phago-
cytes, as follows (phenotype): neutrophils (Ly-6G CD11b F4/80 Ly-6Clow), inflam-
matory monocytes (Ly-6G CD11b F4/80 Ly-6Chigh), large peritoneal macrophages
(LPMs; F4/80 CD11bhigh Ly6C), and small peritoneal macrophages (SPMs; F4/80low
CD11b Ly6C) (23). The influx of neutrophils and monocytes was maximal at 12 h
postinjection (Fig. 2B). Again, the number of recruited phagocytes by PCE was 4 to 5
FIG 2 PCE recruits innate immune cells to the administration site. (A) The effect of staphylococcal envelope on the
recruitment of neutrophils. Various amounts (10, 20, 40, 80, and 160 g) of RN4220-PCE and -SCE and of USA300-PCE (20,
40, and 80 g) were injected i.p. into mice. At 12 h postinjection, peritoneal lavage was carried out. Neutrophils were
stained with fluorescein-conjugated antibodies (see Materials and Methods). Then, the numbers of the fluorescence-
positive cells in 50,000 total cells were measured by FACS. (B) The effect of PCE and SCE on the recruitment of neutrophils,
monocytes, and macrophages. Cells were detected by flow cytometry (Accuri C6 Plus; BD) with the following markers:
neutrophils, Ly-6G CD11b F4/80 Ly-6Clow; inflammatory monocytes, Ly-6G CD11b F4/80 Ly-6Chigh; large peritoneal
macrophages (LPMs), F4/80 CD11bhigh Ly6C; and small peritoneal macrophages (SPMs), F4/80low CD11b Ly6C. (C)
Time-course analysis of chemokine production. Peritoneal fluid was collected as described above. Then, the chemokine
levels (keratinocyte chemoattractant [KC] and monocyte chemoattractant protein [MCP]) were measured by the FACSArray
bioanalyzer and FCAP Array software. Statistical analysis was performed using unpaired Student’s t test (*, P 0.05; **,
P 0.01; ***, P 0.0005).
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times higher than that by SCE. Intriguingly, regardless of the antigens injected, the
number of LPMs was significantly decreased by 6 h postinjection (LPM in Fig. 2B),
whereas the number of SPMs slowly increased until 12 h postinjection (SPM in Fig. 2B).
Nonetheless, there was no significant difference in the numbers of the recruited LPM
and SPM between PCE- and SCE-injected mice, demonstrating that the distinct effi-
ciency of cell recruitment between PCE and SCE applies mainly to neutrophils and
monocytes.
The neutrophil chemokine (C-X-C motif) ligand 1 (CXCL1) and monocyte CC chemo-
kine ligand 2 (CCL2) are known to attract neutrophils or monocytes (24). To understand
the molecular basis of the higher recruitment of neutrophils and monocytes by PCE, we
i.p. injected PCE and SCE into mice and, at various time points, measured the levels of
CXCL1 and CCL2 in the murine peritoneum. Upon injection of PCE, the levels of both
CXCL1 and CCL2 peaked at 3 h postinjection (Fig. 2C). Importantly, the levels of both
chemokines were approximately 10 times higher in PCE-injected mice than those in
SCE-injected mice, suggesting that PCE efficiently recruits neutrophils and monocytes
to the injection site by inducing the secretion of the chemotactic chemokines CXCL1
and CCL2.
Only PCE is internalized by phagocytes and transferred into the mediastinal
lymph node. Next, to examine whether the PCE and SCE are processed differently by
innate immune cells, we labeled PCE and SCE with fluorescein 5-isothiocyanate (FITC).
When the labeling efficiencies of PCE and SCE were examined by comparing the
fluorescence intensities of equal amounts of the samples, no significant difference was
observed (Fig. S3). The FITC-labeled PCE and SCE (40 g each) were injected i.p. into
mice. At 30 min, 1 h, and 2 h postinjection, peritoneal lavage was carried out. Then,
three different peritoneal phagocytes were collected and examined by confocal mi-
croscopy (Fig. 3A). FITC signals were observed only inside the PCE-exposed neutrophils,
LPMs and SPMs (Fig. 3A, left); no FITC signal was detected in the phagocytes exposed
to FITC-SCE (Fig. 3A, right). These results demonstrated that the particulate state of PCE
is critical for the engulfment by host phagocytes.
Of eight draining mouse lymph nodes (LNs), FITC signals were detected only in the
mediastinal LN (mLN) of PCE-injected mice but not in SCE-injected mice (Fig. 3B). In
mLN, the FITC-labeled PCE was found in neutrophils and inflammatory monocytes at 3
h and 6 h postinjection (Fig. 3C). Finally, when the numbers of neutrophils, monocytes,
and dendritic cells in the mLN were measured after 6 h postinjection by flow cytometry,
two to six times more phagocytes were detected in the PCE-injected mice than in
SCE-injected mice (Fig. 3D). These results demonstrate that only PCE is taken up by
phagocytes and transferred into the mLN.
PCE efficiently induces the release of calprotectin into peritoneal fluids. As a
major cytoplasmic protein in neutrophils and monocytes, calprotectin is composed of
myeloid-related protein 8 (MRP8) and 14 (MRP14) (25). The protein has antimicrobial
activity and inhibits bacterial growth by depleting nutrient metals such as zinc and
manganese (26). Also, this protein is an important component of neutrophil extracel-
lular traps (NETs) (27). To examine whether the selective engulfment of PCE by
neutrophils and monocytes affects the release of calprotectin, we injected PCE or SCE
into mice via the i.p. route; then, at 12 h postinjection, peritoneal lavage was carried
out. The peritoneal content was separated into peritoneal cells and peritoneal fluids
(PFs). When equal amounts of the proteins of the peritoneal cell lysates (PCLs) and PFs
were analyzed by 16% Tricine-6 M urea polyacrylamide gel electrophoresis, an 8-kDa
protein band was enriched in the PCLs and PFs of the PCE-injected mice (Fig. 4A,
asterisks). Edman sequencing confirmed that these 8-kDa bands were MRP8 (Fig. S4).
When the PF fractions were further analyzed by Western blotting with antibodies raised
against the commercially available recombinant MRP8 (rMRP8) and recombinant
MRP14 (rMRP14) proteins, the 14-kDa MRP14 was detected only in the PF of PCE-
injected mice (Fig. 4B, left), indicating that only PCE significantly induced the release of
this protein. Intriguingly, with anti-rMRP8 antibody, no protein was detected, even in
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FIG 3 Recruited phagocytes engulf PCE and then migrate to mediastinal lymph node (mLN). (A) Mice
were injected with FITC-PCE (40 g) or FITC-SCE (40 g). Then, 30 min, 1 h, and 2 h later, the peritoneal
cells were collected. Neutrophils (CD11b Ly6C Ly6Ghigh F4/80), small peritoneal macrophages (SPMs;
F4/80low CD11b Ly6C) and large peritoneal macrophages (LPMs; F4/80 CD11bhigh Ly6C) were sorted
by FACSAria high-speed sorter (BD Biosciences). The sorted cells were stained with 1 M PKH26-GL red
(Sigma-Aldrich) for 5 min and observed by confocal microscopy (LSM 700; Zeiss). (B) Six hours after i.p.
injection of FITC-PCE (40 g) or FITC-SCE (40 g), eight different lymph nodes (LNs) were taken; then, LN
(Continued on next page)
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the control lane (lane 5 of Fig. 4B), suggesting that, for an unknown reason, this protein
is missing on the polyvinylidene fluoride (PVDF) membrane.
To understand the detection failure of MRP8 by Western blotting, we purified the
native calprotectin (i.e., nMRP8/nMRP14 complex) from mouse neutrophils and then
subjected the purified proteins to 16% Tricine–6 M urea polyacrylamide gel electro-
phoresis and Coomassie brilliant blue (CBB) staining. As expected, two bands of 14 kDa
and 8 kDa were clearly observed (“Before” in Fig. 4C), indicating that native calprotectin
was purified to homogeneity. When the proteins were electrotransferred onto the PVDF
membrane, although no proteins remained in the PAGE gel, the 8-kDa MRP protein
band was still missing in the PVDF membrane (“After” in Fig. 4C), suggesting that MRP8
passed through the PVDF membrane, probably due to its small size.
Since MRP8 passes through the PVDF membrane, we directly spotted rMRP8,
rMRP14, and the purified calprotectin (nMRP8/nMRP14 complex) on the PVDF mem-
brane and detected the proteins with anti-nMRP8 and anti-nMRP14 antibodies by dot
blot immunoassay. As shown in Fig. 4D, not only rMRP14 but also rMRP8 was detected.
More importantly, the purified calprotectin was also detected by both antibodies (lanes
7 and 14 in Fig. 4D).
With a dot blot immunoassay, we examined the PFs of mice injected with either PCE
or SCE for MRP8 and MRP14 proteins. As shown in Fig. 4E, PFs from PCE-injected mice
contained both MRP8 and MRP14 at much higher levels than those from the SCE-
injected mice (lanes 6 versus 7 and 13 versus 14 in Fig. 4E). As expected, MRP14 was not
detected in MRP14 knockout (KO) mice by PCE injection (Fig. 4F), confirming the
specific secretion of calprotectin by PCE and specificity of the antibodies used in the
assay.
Finally, we examined whether the release of calprotectin conferred antibacterial
activity in the PF. The PFs were collected from the phosphate-buffered saline (PBS)-,
SCE-, and PCE-injected mice at 12 h postinjection; then, the PFs were incubated with
the S. aureus USA300 strain for 3 h. As shown in Fig. 4G, the PFs collected from
PCE-injected mice suppressed bacterial growth approximately five times more than did
the PFs from the SCE-injected mice (lanes 3 versus 4). The addition of MnCl2 to the
PCE-injected PF restored the bacterial growth (lanes 4 versus 5), demonstrating that the
growth suppression was mainly due to the deprivation of manganese ions. Since
manganese deprivation by calprotectin has been reported to reduce the activity of
superoxide dismutase (SOD) of S. aureus, rendering the bacterium more susceptible to
superoxide stress (28), we repeated the growth inhibition assay in the presence of
Paraquat (1,1=-dimethyl-4,4=-bipyridinium dichloride), a superoxide-producing mole-
cule (29). Although the addition of Paraquat reduced bacterial CFU in all samples, the
reduction was most severe in the PF from PCE-injected mice; no bacteria were found
(lane 9 in Fig. 4G), indicating a possible synergistic antibacterial effect of superoxide
and MnCl2 deprivation. Further addition of MnCl2 significantly increased bacterial
survival (lane 10). Taken together, these results demonstrate that PCE, but not SCE, not
only efficiently recruits innate immune phagocytes but also activates the secretion of
the antimicrobial protein calprotectin.
PCE, but not SCE, protects mice from staphylococcal infection. Since PCE
particles induced much more efficient innate immune activation than did SCE, we
further tested whether the activated host innate immunity would lead to better
FIG 3 Legend (Continued)
cells were prepared using a cell strainer. FITC intensity of the cell population was measured by flow
cytometry. (C) After 3 h and 6 h injection of FITC-PCE or FITC-SCE, neutrophils and inflammatory
monocytes of mLNs were gated, and then FITC signal-harboring neutrophils (left) and inflammatory
monocytes (right) were counted by flow cytometry (Accuri C6 Plus; BD). (D) Mice were i.p. injected with
PCE (40 g) or SCE (40 g). Six hours later, mLNs were collected, and the mLN total cells were incubated
with antibody mixture for 10 min at 4°C. The numbers of neutrophils (CD11b Ly6G F4/80), inflam-
matory monocytes (Ly6Chigh CD11b F4/80low Ly6G), and inflammatory DCs (MHC-II CD11c CD11b
Ly-6C) were counted among 50,000 cells by flow cytometry. Statistical analysis was performed using
unpaired Student’s t test (*, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0005; ns, not significant).
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protection against S. aureus infection. PCEs or SCEs were injected i.p. into mice; then,
at 12 h postinjection, the mice were challenged with a lethal dose (5 108 CFU) of the
S. aureus USA300 LAC strain via the i.p. route. As shown in Fig. 5A, PCE protected 90%
of the mice (n 10/group) from S. aureus-mediated death, whereas SCE protected only
20%, confirming that the PCE-mediated activation of innate immunity indeed more
effectively protected the mice from S. aureus infection.
Upon PCE injection, neutrophils and monocytes were the predominant phagocytes
recruited to the injection site (Fig. 2). To examine the roles of the recruited phagocytes
in PCE-mediated protection, we reduced the numbers of neutrophils or monocytes/
macrophages by administering either anti-Ly-6G monoclonal antibody (MAb) (30) or
FIG 4 PCE induces the release of MRP8/14 (calprotectin) from recruited phagocytes. (A) Peritoneal cell lysates (PCLs;
lanes 1 to 3) and peritoneal fluids (PFs; lanes 4 to 6) were obtained at 24 h postinjection of PBS, PCE, or SCE. Then,
20 g of proteins was analyzed by 16% Tricine–6 M urea–0.1% SDS gel and Coomassie blue stain. Asterisks indicate
enriched proteins in PCL and PF with 8-kDa molecular size. ‹, additional 7-kDa band in PF collected from
PCE-injected mice. (B) Twenty microliters of PFs was further analyzed by Western blot analysis with anti-rMRP8 and
anti-rMRP14 Abs (R&D Systems). (C) The same amounts (10 g) of purified native MRP8 (nMRP8) and MRP14
(nMRP14) were separated on 16% Tricine–6 M urea–0.1% SDS gel and stained with Coomassie blue dye (“Before”).
The proteins were subsequently electrotransferred onto PVDF membrane (“After”). (D) Determination of antibody
specificity for rMRP8, rMRP14, or nMRP8/14. The proteins were dissolved in 50% ethanol, and the indicated
amounts of proteins were spotted onto the PVDF membrane. Then, an immunoassay was carried out with
anti-nMRP14 and anti-nMRP8 Abs. (E) Dot blot immunoassay to measure the release of MRP8 and MRP14 proteins
into PFs. The rMRP8 (0.5 g), rMRP14 (0.5 g), purified nMRP8/14 (0.5 g), and PFs from SCE- or PCE-injected mice
(0.5 g in 20 l) were spotted on the PVDF membranes and subjected to the immunoassay with anti-nMRP8 and
anti-nMRP14 antibodies. (F) PCE (40 g) or SCE (40 g) was injected i.p. into C57BL/6 WT and MRP14 deficient
C57BL/6 S100A9/ knockout mice. At 12 h postinjection, PFs were collected. The presence of MRP14 protein in
each PF was examined by Western blot analysis with anti-rMRP14 Ab. (G) The antibacterial activity of PFs collected
from SCE- or PCE-injected mice. PFs were mixed with USA300 cells in the absence (columns 1 to 5) and the
presence (columns 6 to 10) of 1 mM Paraquat. To examine the effect of MnCl2, MnCl2 (10 M) was added to PCE-PF.
After 12 h of incubation, PFs were spread on the blood agar, and the CFU were measured.
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clodronate liposome (31, 32) via the tail vein. At 24 h postadministration, PCE was
injected i.p. into the mice. Then, at 12 h postinjection, after confirming the reduced
numbers of neutrophils or monocytes and macrophages (LPMs and SPMs) by flow
cytometry (Fig. S5), the mice were challenged with a lethal dose of USA300 cells
(5 108 CFU) via i.p. injection. As shown in Fig. 5B, all neutrophil-depleted mice
(n 8/8) died within 1 day, while, upon depletion of monocytes and macrophages,
only one mouse (n 1/8) survived by day 7. In contrast, all control mice (8 for isotype
antibody [Ab] and 7 for control liposome) survived until day 7, demonstrating that both
neutrophils and monocytes/macrophages play critical roles in the PCE-mediated pro-
tection against S. aureus infection.
DISCUSSION
Many bacterial cell envelope components function as innate immune molecules for
host immunity (33). However, how the physical states of the bacterial cell envelope,
particulate versus soluble, affect their immune activation efficiency is not studied. Here,
we provide biochemical and immunological evidence that the particulate state of the
staphylococcal cell envelope is required for efficient innate immune activation. Also, we
showed that this innate immune activation and protection involve both neutrophils
and monocytes/macrophages. In a recent work, the Underhill group reported that
particulate fungal -glucans of Saccharomyces cerevisiae cell wall activate the dectin-1
receptor via the formation of phagocytic synapse and triggering of the downstream
FIG 5 PCE-mediated innate immune response protects host from S. aureus infection. (A) The effect of PCE and SCE
administration on the host survival. Phosphate-buffered saline (PBS; black circles), SCE (40 g, red squares), and PCE
(40 g, blue triangles) were injected i.p. into 10 mice. At 12 h postinjection, USA300 cells were administered via i.p.
injection, and the infected mice were watched for 5 days. (B) The role of neutrophils or monocytes/macrophages
in the PCE-mediated protection against staphylococcal infection. Prior to PCE injection, the phagocytes were
reduced by injecting anti-Ly-6G MAb (neutrophils) or clodronate liposome (monocytes/macrophages). Isotype-
matched control antibody (i.e., rat IgG2a) and empty liposome were used as controls. After 12 h of PCE injection,
the mice (n  7 to 8) were challenged with i.p. injection of USA300 LAC cells (5 108 CFU/mouse) and observed
for 7 days. Statistical significance of the murine survival between the PBS control condition (black circle) and the
other test conditions was measured by log rank test. ***, P 0.005; ****, P 0.0001; n.s., not significant.
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signaling events, resulting in the generation of reactive oxygen species (ROS) and the
induction of antimicrobial activity (34). Like live fungi, the -glucan particles caused the
clustering of dectin-1 molecules and the formation of phagocytic cups. However, as
with our observation with staphylococcal SCE, the soluble -glycans failed to do so.
These observations indicate that, for efficient innate immune defense against both
bacteria and fungi, the particulate state of the invading pathogen is essential.
Despite the same antigenic composition, why is PCE much more efficient in innate
immune activation than SCE? Although the exact molecular mechanisms are not yet
clear, the higher local antigen density and the colocalization of multiple immune
activators of the PCE likely contribute to the efficient receptor binding and subsequent
innate immune activation. On the contrary, the injected SCE will disperse easily and be
present at a much lower local concentration, which in turn is expected to lead to
inefficient immune activation. Also, the particulate state itself seems to play a positive
role in immune activation. For example, polystyrene particles measuring 430 nm to
1 m efficiently activate dendritic cells to produce interleukin-1 beta (IL-1) (35). The
optimal size of silica for the engulfment by macrophages is approximately 1 m (36).
Therefore, the facile phagocytosis of PCE (Fig. 3) is also likely to contribute to the
efficient antigen processing and innate immune activation, leading to the induction of
subsequent antimicrobial responses, such as ROS production and calprotectin secre-
tion.
Until this study, three molecules, uric acid (15), host DNA, (37) and lipid derivatives
(38), were reported to be released from host cells upon injection of particulate
adjuvants. Here, we provide the first biochemical evidence that staphylococcal PCE can
also release calprotectin from host phagocytes (Fig. 4). The antimicrobial activity of
calprotectin is expected to contribute to the faster elimination of S. aureus cells in the
PCE-injected mice (Fig. 5A). If calprotectin was released by PCE, it is possible that other
intracellular molecules, including DNA, can also be released. Since both DNA and
calprotectin are important components of NETs (27), it is plausible that PCE also
induced NET formation, which in turn further contributes to the elimination of bacterial
cells. It remains to be determined how PCE induces the release of calprotectin from the
phagocytes.
In this study, the injected i.p. PCE specifically migrated to the mediastinal LNs (Fig.
3B). Similar results were also reported previously with live Listeria monocytogenes or
Indian ink particles (39). Upon i.p. injection, the live L. monocytogenes and Indian ink
particles were phagocytosed by intraperitoneal macrophages and neutrophils and
transported into the mLNs before they were spread to other body parts. The host
phagocytes containing PCE or live bacterial cells probably migrate to mLNs via the
afferent lymphatic vessels, giving rise to inflammatory responses. Therefore, it is likely
that during intraperitoneal infections, the mediastinal LNs serve as a focal point from
which the infectious agents will spread to adjoining organs, such as the liver, spleen,
and kidneys, via the phagocytes.
Compared with peritoneal cell lysates (PCLs), peritoneal fluids (PFs) generated a
unique 7-kDa band (‹ in Fig. 4A). Despite multiple trials to purify the protein or to
analyze it with liquid chromatography-tandem mass spectrometry (LC-MS/MS), we
failed to identify the nature of this band. Intriguingly, the 7-kDa band pattern is similar
to that of the modified MRP8 band (40). Neutrophil-derived MRP8 and MRP14 are
known to be readily S-nitrosylated at conserved cysteine residues by nitric oxide (NO)
donors, such as S-nitroso-N-acetyl-penicillamine, in vitro (40). Although we cannot rule
out the possibility that the 7-kDa protein is not MRP8, it is also possible that the unique
7-kDa band is the modified MRP8 protein. If that is the case, the absence of the 7-kDa
band in peritoneal cell lysates suggests that the modification of the protein occurs
during or after the release of the proteins. If so, it is of interest to determine what types
of modifications occur to the proteins and whether the modifications affect the
antimicrobial function of the proteins.
Upon recognition of bacterial cell wall components by receptors, the production of
proinflammatory mediators, such as cytokines and chemokines, leads to infiltration of
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neutrophils and macrophages, which are directly involved in the clearance of the
pathogens (24). Also, the innate immune cells have the potential to elicit effective
adaptive immunity, including helper T cell-mediated antibody production, and confer
relatively long-term protective immunity (4). In the present study, we observed a
release of calprotectin into the peritoneal fluid as a specific host defense molecule and
migration of PCE-engulfed phagocytic cells into the mLNs upon injection. It will be
interesting to see how PCE and SCE elicit different effects on acquired immunity in
comparison to a well-known particulate adjuvant, such as alum.
Our findings in this study support the importance of the particulate state of the cell
envelope in augmenting the host immune responses by the recruitment of host
phagocytes. These phagocytes are capable of producing nonspecific antimicrobial
molecules, such as calprotectin and ROS, and effectively eliminate invading S. aureus
(39). However, unlike PCE, the live bacterium is capable of producing multiple toxins
targeting those host phagocytes (40). For example, gamma-hemolysin AB and CB
(HlgAB and HlgCB), the leucocidin AB and ED (LukAB and LukED), and Panton-Valentine
leucocidin (PVL) can kill neutrophils, monocytes, and macrophages (41), rendering the
host susceptible to S. aureus infection. Therefore, to develop a novel antitherapeutic
agent against S. aureus infection, not only the bacterial antigens activating host
immune responses but also the anti-toxin antibodies or toxin-neutralizing components
should be considered.
MATERIALS AND METHODS
Ethics statement. Age- and sex-matched wild-type C57BL/6 mice, purchased from Orient Bio
(Charles River Breeding Laboratories Korea), were kept in microisolator cages in a pathogen-free animal
facility. The experiments were performed according to the institutional guidelines and approval (PNU-
2017-1503) of the Pusan National University Institutional Animal Care and Use Committee (PNU-IACUC).
Animal experiments using calprotectin-deficient (C57BL/6 S100A9/) mice were performed at the
Indiana University School of Medicine-Northwest (IUSM-NW), according to the protocol (NW-43) ap-
proved by the Institutional Animal Care and Use Committee of IUSM-NW. The calprotectin-deficient mice
were acquired from the Vanderbilt University School of Medicine under permission from the University
of Muenster. Every effort was made to minimize the suffering of the animals.
Bacteria. For the preparation of staphylococcal PCE and SCE samples, we used the S. aureus RN4220
wild-type strain (41), the LTA-deficient RN4220 ΔltaS mutant strain (42), and the lipoprotein-deficient
RN4220 Δlgt mutant strain (43). The USA300 strain (44) was used for infection experiments.
Proteins. S. aureus SitC protein was purified as described previously (43). Native MRP8 (nMRP8) and
native MRP14 (nMRP14) proteins were purified as described previously (45). Briefly, 1 ml of 9% casein
solution (9 g of casein [Merck] dissolved in 100 ml of PBS [Lonza] containing 0.9 mM CaCl2 and 0.6 mM
MgCl2 [pH 7.2]) was i.p. injected into mice (BALB/c, 9 weeks old, male, five mice/group). At 12 h
postinjection, peritoneal fluid was collected with the harvest solution (PBS containing 0.05 mM EDTA),
and then peritoneal exudate cells (PECs) were obtained by centrifugation at 300 g and 4°C for 10 min.
Using PECs, the neutrophils were separated using MACS cell separation columns (Miltenyi Biotec) and a
neutrophil isolation kit (Miltenyi Biotec), following the manufacturer’s recommended protocols. The
collected neutrophils (5 107 cells from five mice) were added to 20 ml of cell lysis solution (25 mM
Tris-HCl [pH 8.0], 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol [DTT]). After suspension, ammonium
sulfate powder (14.33 g) was added to 100% (wt/vol) final concentration. After 1 h, the mixture was
centrifuged at 20,400 g and 4°C for 30 min. After collection of the supernatant, 100% trichloroacetic
acid (TCA) solution was added to 10% and incubated at 4°C for 60 min. After centrifugation at 20,400 g
and 4°C for 30 min, the obtained pellet was neutralized to pH 7.0 with 1 M KOH. The purity of the
obtained pellet was examined by 16% Tricine–6 M urea–0.1% SDS gel or by a 15% SDS-PAGE gel under
reducing conditions.
Preparation of PCE and SCE. PCEs and SCEs were prepared according to our published methods (17,
46), with some modification. Briefly, cultured S. aureus RN4220 cells were treated with 70% chilled
ethanol for 1 h at 4°C. Subsequently, the killed bacteria were collected by centrifugation at 3,000 g and
4°C for 10 min and washed three times with 20 ml of double-distilled water (DDW). The collected
bacterial cells were lyophilized. Two hundred milligrams of lyophilized ethanol-killed bacteria was mixed
with 12 g glass beads (diameter distributions between 0.10 and 0.11 mm; Sartorius AG, Inc.) in 20 ml of
buffer A (20 mM citrate [pH 4.7], 1 M NaCl) and then disrupted with grinding homogenizer (Retsch,
MM400 type). The glass beads were removed by centrifugation at 1,400 g and 4°C for 10 min, and the
cell envelope fraction was collected. The collected cell envelope was centrifuged again at 20,400 g and
4°C for 10 min. After discarding the supernatant, the pellet was washed twice with 10 ml of buffer A.
The pellet was suspended in 10 ml of buffer A and mixed with 10 ml of buffer A containing 1% SDS. The
mixture was incubated at 60°C for 30 min and centrifuged at 20,400 g and 20°C for 5 min. The
remaining SDS was completely washed out from the pellet with DDW, and the pellet was finally
suspended in DDW. The insoluble cell envelope suspension was frozen at –80°C and subsequently
lyophilized. The obtained insoluble particulate cell envelope was referred to as PCE. Twenty milligrams
Immune Response by the Staphylococcal Cell Envelope Infection and Immunity
December 2019 Volume 87 Issue 12 e00674-19 iai.asm.org 11
of lyophilized PCE was suspended with 1 ml of 25 mM phosphate buffer (pH 8.0), mixed with 80 g of
recombinant lysostaphin (LSPN; Ambi), and incubated at 37°C for 1 h. Afterwards, 4 g of recombinant
lysozyme (Lysobac; InViTRIA) was added, and the sample was again incubated at 37°C for 1 h. The enzymes
were inactivated at 60°C for 10 min and centrifuged at 216,000 g and 4°C for 30 min. The supernatant
was frozen at –80°C and lyophilized. The residue was referred to as SCE.
Quantification of D-Ala and GlcNAc in PCE and SCE. The amounts of D-Ala and of GlcNAc in PCE
and SCE were measured as described previously (17, 46–49). To measure the amounts of D-Ala, three
different batches (30 g each) of PCE and SCE were incubated in 0.1 M NaOH at 37°C for 2 h and
separated by thin-layer chromatography on silica gel 60 (Merck, Darmstadt, Germany) in a solvent
consisting of n-propanol:pyridine:acetic acid:water (18:10:5:16). Then, the plate was treated with ninhy-
drin reagent to visualize amino groups of D-Ala residue, and the D-Ala amounts on the plate were
quantified by a scanner (GDS200; Korea Lab Tech). The GlcNAc amounts in SCE and PCE were quantified
as described previously (50). Briefly, three different batches (200 g each) of SCE and PCE were
hydrolyzed in 6 N HCl at 100°C for 3 h in vacuo, which is necessary to avoid the degradation of GlcNAc
residues in the oxygen. Then, GlcNAc was quantified with the Morgan-Elson reagent.
Measurements of particle size. The mean and median particle sizes of PCE and SCE in PBS were
determined by a laser diffraction particle size analyzer (LS12 320 model; Beckman Coulter Co.).
WTA preparation from WT-PCE. WTA was prepared according to our published method (17), with
some modifications. Briefly, to release WTA, PCE (200 mg) was suspended in 10 ml of 12.5% TFA and
incubated at 37°C for 12 h. The digested materials were centrifuged, and the WTA in the supernatant was
precipitated with cold acetone. The ribitol phosphate moieties of the released WTA were confirmed by
a 27% PAGE gel and alcian blue silver staining (19).
Analyses of chemokines and cytokines. One hundred micrograms of PCE and SCE in 100 l of PBS
was injected i.p. into the mice, and then the peritoneal lavage was carried out at 0, 1.5, 3, 6, 12, and 24
h postinjection with 5 ml of Hanks balanced salt solution (HBSS; Gibco) containing 0.5% bovine serum
albumin (BSA) and 2 mM EDTA. The collected fluid was centrifuged at 4°C and 300 g for 5 min. The
supernatants were transferred to a 500-l tube and kept at –80°C until use. Chemokine and cytokine
levels were quantified with cytometric bead array mouse flex sets (BD Biosciences) and analyzed with
FACSArray bioanalyzer and FCAP Array software.
Immunodot blotting. To confirm the presence of LTA in the SCEs or the detection of calprotectin
in peritoneal cell lysates (PCLs) and peritoneal fluids (PFs), the immunodot blotting was carried out as
described previously (51). Briefly, after activation of a PVDF membrane with methanol, samples were
mixed with ethanol (final 50% concentration), spotted on the membrane, and dried. The membrane was
blocked by soaking in 5% skim milk in 20 mM TBST (Tris-buffered saline [pH 7.4] containing 0.1% Tween
20) at room temperature (RT) for 1 h and then incubated with primary antibodies (1/500 dilution of
anti-nMRP8 Ab and 1/1,000 dilution of anti-nMRP14 Ab) dissolved in skim milk-TBST at room temperature
for 1 h. The membrane was washed three times with TBST for 10 min and incubated with secondary
antibody conjugated with horseradish peroxidase (HRP; 1/5,000; Santa Cruz) at room temperature for
30 min. The membrane was washed three times with TBST for 10 min, incubated with enhanced
chemiluminescence (ECL) reagent for 1 min, and then imaged with the Bio-Rad ChemiDoc system.
Flow cytometry. The following antibodies were purchased from either BD Biosciences or eBiosci-
ence: Ly-6G-APC, F4/80-PE, CD11b-FITC, and Ly-6C-PerCP (APC, allophycocyanin; PE, phycoerythrin;
PerCP, peridinin chlorophyll protein). Typically, 200,000 cells were stained with specific MAbs after
blockage of nonspecific binding by FcR blocking reagent (Miltenyi Biotec). Stained cells were analyzed
on an Accuri C6 Plus flow cytometer (BD), and 10,000 to 20,000 events were collected for each analysis.
Flow data were analyzed using the FlowJo software (Tree Star, Inc.).
Labeling of antigen with FITC. FITC labeling of PCEs or SCEs was performed using a method
described by Tino and Wright (52). Briefly, PCE or SCE (10 mg) was suspended in 0.1 M sodium carbonate
buffer (pH 8.5). Stock solution (1 mM) of fluorescein isothiocyanate (FITC; Sigma-Aldrich) was prepared
with anhydrous dimethyl sulfoxide. One hundred microliters of FITC stock solution was added to PCE and
SCE to a final concentration of 0.02 mM and then incubated at RT for 1 h. FITC-labeled PCE was washed
out with DDW to remove unbound FITC. FITC-labeled SCE was separated from unbound FITC with
Sephadex25 desalting column (GE Healthcare) connected to a high-performance liquid chromatography
(HPLC) system (Gilson). Both samples were lyophilized and stored at 80°C until use.
To compare the FITC labeling efficiency, 1 mg of each of the lyophilized FITC-SCE and FITC-PCE was
suspended in 1 ml PBS. Then, 40 l of the samples was transferred into the wells of a black-colored
96-well plate (SPL Life Sciences), and fluorescence was measured using a multimode microplate reader
(TriStar LB 941; excitation, 460 nm; emission, 510 nm, Berthold Technologies GmbH & Co.). This mea-
surement was repeated two more times.
Phagocytosis analyses of FITC-labeled PCE and SCE. The phagocytosis assay was carried out by a
method described by Geertsma et al. (53). Briefly, 40 g of FITC-labeled PCE or SCE was injected i.p. into
mice (five per group). At 30 min, 1 h, and 2 h postinjection, peritoneal cells were collected in RPMI
medium containing 10% serum at 4°C and used immediately for sorting in the flow cytometer and cell
sorter (FACSAria III; BD Biosciences). Three different types of phagocytes (i.e., neutrophils, small perito-
neal macrophages [SPMs], and large peritoneal macrophages [LPMs]) were sorted. Cells (2 104) were
mounted on a glass slide and incubated with 500 l of 4% paraformaldehyde at room temperature for
10 min. The attached cells were stained with 2 M PKH26-GL red (a fluorescent lipid-intercalating dye;
Sigma-Aldrich) at 37°C for 5 min. To quench the fluorescence of the cell surface, cells were incubated with
300 l of 0.4% trypan blue solution (Sigma-Aldrich) for 5 min. The cells were washed three times with
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1 ml of PBS. After dropping 5 l of fluorescent mounting solution (catalog no. S3023; Dako) on the glass
slides, cells were examined with confocal microscopy (LSM 700; Zeiss).
Migration analysis of FITC-PCE and -SCE into LNs. The lymphatic drainage of FITC-PCE or -SCE into
the peritoneal cavity was examined, as previously described (39). Briefly, 100 g of FITC-labeled PCE or
SCE was injected i.p. into mice (two mice per group). After 6 h, mice of each group were killed, and then
eight LNs (mesenteric, mediastinal, lumbar, superficial cervical, brachial, axillary, inguinal, and sciatic)
were collected in ice-chilled tubes. Single-cell suspensions were prepared from the collected LNs using
a cell strainer (BD Biosciences), and then 2.5 105 cells were suspended with fluorescence-activated cell
sorting (FACS) buffer (PBS containing 0.5% BSA and 2 mM EDTA). The mean fluorescence intensity (MFI)
of the samples was measured with an Accuri C6 Plus flow cytometer (BD Biosciences) and analyzed with
the FlowJo software (Tree Star).
Analysis of neutrophil recruitment to the peritoneal cavity after injection of different amounts
of RN4220-PCE, RN4220-SCE, and USA300-PCE. Mice were injected i.p. with various amounts of
RN4220-PCE, RN4220-SCE, or USA300-PCE, as described above. At 12 h postinjection, peritoneal fluids
were collected with 5 ml of Hanks balanced salt solution (HBSS) containing 0.5% bovine serum albumin
(BSA) and 2 mM EDTA. Peritoneal cells were collected by centrifugation (4°C, 300 g, 5 min) and
suspended in 500 l of MACS buffer (PBS containing 0.5% BSA and 2 mM EDTA). After cell counting by
flow cytometry, 1 106 cells were suspended in 40 l of MACS buffer. Five microliters of FcR blocking
reagent (130-092-575; Miltenyi Biotech) was added and incubated at 4°C for 10 min. Five microliters of
antibody mixture (Ly-6G-APC, F4/80-PE, CD11b-FITC, Ly-6C-PerCP; BD Biosciences) was added and
incubated at 4°C for 10 min, and 1 ml of MACS buffer was added. After centrifugation at 4°C and 300 g
for 5 min, pellets were suspended in 200 l of MACS buffer, and 50,000 cells were analyzed by flow
cytometry (Accuri C6 Plus flow cytometer; BD Biosciences). The neutrophil population was calculated
using numbers of CD11b Ly6G/F4/80/Ly-6Clow cells by the FlowJo software (Tree Star, Inc.).
Analysis of neutrophils and monocytes in mLNs.Mice were injected i.p. with 40 g of RN4220-PCE
or -SCE, as described above. At 3 h and 6 h postinjection, mLNs were collected, and then a single-cell
suspension was prepared using a cell strainer (BD Biosciences). The cells were suspended in FACS buffer.
The cell suspension (40 l) was mixed with 5 l of FcR blocking reagent and incubated at 4°C for 10 min.
To detect neutrophils and monocytes, 10 l of antibody stock solution was added to each tube, which
was then incubated at 4°C for 10 min. Then, 1 ml of FACS buffer was added to each tube for washing,
followed by centrifugation at 4°C, 300 g for 10 min, and then the supernatant was removed. Finally,
each pellet was suspended with 100 l of 4% paraformaldehyde for fixation. After the pellets were
washed with FACS buffer, the samples were analyzed using flow cytometry (Accuri C6 Plus flow
cytometer; BD) and FlowJo software. Neutrophils and monocytes were identified with Ly-6G CD11b
F4/80 Ly-6Clow and Ly-6G CD11b F4/80 Ly-6Chigh monoclonal antibodies, respectively.
Analyses of dendritic cell population in mLN by flow cytometry. For analyses of the cell
populations in mLNs, 40 g of PCE or SCE was injected i.p. into mice (five per group). At 6 h postinjection,
the mLNs were collected and centrifuged at 4°C and 300 g, and the supernatants were removed.
Pellets were suspended in 500 l of FACS buffer. After calculation of the total cell numbers by a flow
cytometer, the pellets were suspended in FACS buffer to 5 105 cells/40 l. Flow cytometer analyses
were performed as described above. The inflammatory dendritic cells (DCs) were identified by MHC-II
CD11c CD11b Ly-6C (MHC-II, major histocompatibility complex class II) monoclonal antibody.
Measurement of calprotectin-mediated antibacterial activity. Calprotectin-mediated antibacte-
rial activity was measured by a method reported previously (54). Briefly, after injection of 100 g of PCE
or SCE, 300 l of collected PFs was incubated with USA300 cells (5 106 CFU) in 30% tryptic soy broth
(TSB) medium in the presence (0.1 mM) or absence of Paraquat (Sigma-Aldrich). After incubation for 3 h,
reaction solutions were spread on tryptic soy agar (TSA) plates. To assess the effects of metal ions, 10 mM
MnCl was added to the solution (10 M final concentration), and then the mixture was incubated at 37°C
for 12 h and spread on plates.
Animal experiments. To measure the protective effect of PCE or SCE in a murine model of peritoneal
infection, 6-week-old C57BL/6J mice (10 per group) were i.p. injected with SCE or PCE (40 g). At 12 h
postinjection, mice were injected i.p. with 5 108 CFU of the S. aureus USA300 strain. The mice were
observed twice per day for 5 days.
To examine the roles of phagocytes in the PCE-mediated protective effect, 5-week-old C57BL/6J mice
(six per group) were injected i.p. with anti-Ly6G MAb (100 g, clone 1A8; Bio X Cell) or clodronate
liposomes (200 l; FormuMax) (55, 56). As controls, isotype Ab (100 g, rat IgG2a, clone 2A3; Bio X Cell)
and empty liposome (200 l; FormuMax) were injected.
At 24 h postadministration, peritoneal lavage was carried out with 5 ml of Hanks balanced salt
solution (HBSS) containing 0.5% bovine serum albumin (BSA) and 2 mM EDTA. Peritoneal cells were
collected by centrifugation (4°C, 300 g, 5 min) and suspended in 500 l of MACS buffer (PBS containing
0.5% BSA and 2 mM EDTA). After cell counting by flow cytometry, 1 106 cells were suspended in 40 l
of MACS buffer. Five microliters of FcR blocking reagent (130-092-575; Miltenyi Biotech) was added and
incubated at 4°C for 10 min. Five microliters of antibody mixture (Ly-6G-APC, F4/80-PE, CD11b-FITC, and
Ly-6C-PerCP; BD Biosciences) was added and incubated at 4°C for 10 min, and 1 ml of MACS buffer was
added. After centrifugation at 4°C and 300 g for 5 min, pellets were suspended with 100 l of 4%
paraformaldehyde, and 40,000 cells were analyzed by flow cytometry (Accuri C6 flow cytometer Plus; BD).
Reduction of the neutrophils and monocytes/macrophages was examined by flow cytometry analysis of
peritoneal cavity cells for CD11b Ly6G (neutrophils), CD11b Ly-6G (monocytes), F4/80 CD11bhigh
Ly6C (LPMs), and F4/80low CD11b Ly6C (SPMs). After confirmation of the reduction of neutrophils,
monocytes, and macrophages (LPMs and SPMs) by flow cytometry (Fig. S5), the mice (n  7 to 8 mice)
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were injected with PCE (40 g), and 12 h later, they were challenged with i.p. injection of USA300 LAC
cells (5 108 CFU/mouse). The infected mice were observed for 7 days.
Data processing and statistical analysis. Unless otherwise stated, experiments were carried out at
least three times independently, and the results were presented as the mean  standard deviation (SD).
Other experimental results are representative of at least three independent experiments that yielded
similar results. Statistical significance was measured by unpaired Student’s t test or log rank test with the
GraphPad Prism software.
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